Spyre Therapeutics Inc. (SYRE) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Spyre Therapeutics Inc.

    NASDAQ: SYRE · Real-Time Price · USD
    17.00
    0.01 (0.06%)
    At close: Sep 05, 2025, 3:59 PM
    17.00
    0.00%
    After-hours: Sep 05, 2025, 04:10 PM EDT

    Spyre Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -208.02M -338.79M -83.81M -65.8M
    Depreciation & Amortization
    		 n/a 744K 1.57M 1.58M
    Stock-Based Compensation
    		 44.83M 25.68M 7.11M 8.04M
    Other Working Capital
    		 -4.3M -5.8M -2.86M 768K
    Other Non-Cash Items
    		 10.31M 217.67M 823K 90K
    Deferred Income Tax
    		 n/a n/a -327K 548K
    Change in Working Capital
    		 -4.53M -5.21M -5.5M 1.83M
    Operating Cash Flow
    		 -157.41M -99.91M -80.14M -53.72M
    Capital Expenditures
    		 n/a n/a -38K -573K
    Cash Acquisitions
    		 n/a 3.04M n/a n/a
    Purchase of Investments
    		 -599.25M -166.8M -39.5M -133.08M
    Sales Maturities Of Investments
    		 245.97M 39.9M 96.55M 111.03M
    Other Investing Acitivies
    		 n/a 15.47M n/a n/a
    Investing Cash Flow
    		 -353.29M -108.39M 57.01M -22.62M
    Debt Repayment
    		 n/a -16K -418K -510K
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 -1.43M -5.38M 222K 1.9M
    Financial Cash Flow
    		 410.91M 361.08M 42.68M 1.39M
    Net Cash Flow
    		 -99.79M 152.8M 19.44M -74.96M
    Free Cash Flow
    		 -157.41M -99.91M -80.18M -54.29M

    Add to Watchlist